Information Journal Paper
APA:
Copy. (2017). SGLT2 inhibitors as a therapeutic option for diabetic nephropathy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 18(5), 0-0. SID. https://sid.ir/paper/731651/en
Vancouver:
Copy. SGLT2 inhibitors as a therapeutic option for diabetic nephropathy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES[Internet]. 2017;18(5):0-0. Available from: https://sid.ir/paper/731651/en
IEEE:
Copy, “SGLT2 inhibitors as a therapeutic option for diabetic nephropathy,” INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol. 18, no. 5, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/731651/en